Guidelines for the management of rheumatoid arthritis: 2002 Update.
暂无分享,去创建一个
[1] H. Holman,et al. Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.
[2] J. Jacobs,et al. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial , 2000, Annals of the rheumatic diseases.
[3] R. Dahl,et al. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. , 2000, Rheumatology.
[4] A. Cats,et al. Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study. , 1986, Annals of the rheumatic diseases.
[5] D. M. Chaput de Saintonge,et al. Azathioprine in rheumatoid arthritis: double-blind study of full versus half doses versus placebo. , 1981, Annals of the rheumatic diseases.
[6] D. Scott,et al. Prognostic factors in early rheumatoid arthritis. , 2000, Rheumatology.
[7] J. Kremer. Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: followup after a mean of 13.3 years. , 1997, Arthritis and rheumatism.
[8] M. Hochberg,et al. Adult and juvenile rheumatoid arthritis: current epidemiologic concepts. , 1981, Epidemiologic reviews.
[9] J J Anderson,et al. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials , 1993 .
[10] C. Ranawat. Surgical management of the rheumatoid hip. , 1998, Rheumatic diseases clinics of North America.
[11] Richard W. Martin,et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. , 2000, The New England journal of medicine.
[12] M. Urowitz,et al. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1992, Arthritis and rheumatism.
[13] J. Senior,et al. Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs , 1995, Annals of Internal Medicine.
[14] B. Dijkmans,et al. A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. , 1994, Arthritis and rheumatism.
[15] J. Lifson,et al. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. , 1985, Annals of internal medicine.
[16] Minocycline in active rheumatoid arthritis , 1994 .
[17] M. Ahern,et al. A randomised double-blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis. , 1991, Australian and New Zealand journal of medicine.
[18] M. Corbett,et al. Radiographic changes in early rheumatoid disease. , 1977, Annals of the rheumatic diseases.
[19] N. Cooper. Economic burden of rheumatoid arthritis: a systematic review. , 2000, Rheumatology.
[20] T. Möttönen,et al. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. , 1988, Annals of the rheumatic diseases.
[21] M. A. van 't Hof,et al. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. , 1992, Arthritis and rheumatism.
[22] L. V. D. van de Putte,et al. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. , 1997, British journal of rheumatology.
[23] F. Breedveld,et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. , 1998, Arthritis and rheumatism.
[24] M. Guttadauria,et al. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1985, Arthritis and rheumatism.
[25] B. Kramer,et al. Effects of exercise on fatigue, aerobic fitness, and disease activity measures in persons with rheumatoid arthritis. , 1997, Research in nursing & health.
[26] J. Kremer,et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. , 1999, The New England journal of medicine.
[27] G. Alarcón,et al. Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. , 1989, Arthritis and rheumatism.
[28] P. Tugwell,et al. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled t , 2000, Arthritis and rheumatism.
[29] M. Weinblatt,et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. , 1985, The New England journal of medicine.
[30] D. Felson,et al. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach. , 1999, Arthritis and rheumatism.
[31] H. Paulus,et al. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. , 1990, Arthritis and rheumatism.
[32] J. Smolen,et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial , 1999, The Lancet.
[33] J. Klippel,et al. Second-line drug therapy for rheumatoid arthritis. , 1994, The New England journal of medicine.
[34] M. A. van 't Hof,et al. Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis , 2001, Annals of the rheumatic diseases.
[35] D. Furst,et al. Etanercept Therapy in Rheumatoid Arthritis , 1999, Annals of Internal Medicine.
[36] M. Guttadauria,et al. Methotrexate in Rheumatoid Arthritis: Impact on Quality of Life Assessed by Traditional Standard-Item and Individualized Patient Preference Health Status Questionnaires , 1990 .
[37] M. Urowitz,et al. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis , 1992 .
[38] P. Brooks,et al. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine. , 1992, Annals of the rheumatic diseases.
[39] M. Miller,et al. Tenidap in rheumatoid arthritis. A 24-week double-blind comparison with hydroxychloroquine-plus-piroxicam, and piroxicam alone. , 1995, Arthritis and rheumatism.
[40] J. Moreland,et al. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. , 1971, Arthritis and rheumatism.
[41] J. Esdaile,et al. Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial. , 1993, Arthritis and rheumatism.
[42] D. Stablein,et al. Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment. , 1995, Arthritis and rheumatism.
[43] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[44] D. Hungerford,et al. Eliminating patellofemoral complications in total knee arthroplasty: clinical and radiographic results of 121 consecutive cases using the Duracon system. , 1999, The Journal of arthroplasty.
[45] J. Kremer,et al. Combination Therapy with Multiple Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Preventive Strategy , 1999, Annals of Internal Medicine.
[46] V. Strand,et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. , 1999, Archives of internal medicine.
[47] J. O'dell,et al. Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial. , 1999, Arthritis and rheumatism.
[48] S. Pillemer,et al. Minocycline in Rheumatoid Arthritis: A 48-Week, Double-Blind, Placebo-Controlled Trial , 1995, Annals of Internal Medicine.
[49] M. Wolfe,et al. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. , 1999, The New England journal of medicine.
[50] T. Pullar,et al. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. , 1983, British medical journal.
[51] J. O'dell,et al. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. , 1997, Arthritis and rheumatism.
[52] G. Alarcón,et al. Supplementation with Folic Acid during Methotrexate Therapy for Rheumatoid Arthritis: A Double-Blind, Placebo-Controlled Trial , 1994, Annals of Internal Medicine.
[53] J. Kremer,et al. Methotrexate for Rheumatoid Arthritis , 1994 .
[54] P. Hannonen,et al. Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study. , 1993, Arthritis and rheumatism.
[55] D. Heijde,et al. EFFECTS OF HYDROXYCHLOROQUINE AND SULPHASALAZINE ON PROGRESSION OF JOINT DAMAGE IN RHEUMATOID ARTHRITIS , 1989, The Lancet.
[56] V. Strand,et al. Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis , 1995 .
[57] M. Hochberg,et al. Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1996 .
[58] R N Maini,et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. , 2000, The New England journal of medicine.
[59] C. Hawkey,et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. , 1996, The New England journal of medicine.
[60] J. Kirwan,et al. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. , 1995, The New England journal of medicine.
[61] C. Kwoh,et al. Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. , 1996, Arthritis and rheumatism.
[62] P. Tugwell,et al. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. , 1999, Arthritis and rheumatism.
[63] E. Yelin,et al. An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline. , 1999, Arthritis and rheumatism.
[64] J. Kremer,et al. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. , 1999, Arthritis and rheumatism.
[65] A. Stewart,et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. , 1999, Medical care.
[66] J. Hazes,et al. Dynamic exercise therapy in rheumatoid arthritis: a systematic review. , 1998, British journal of rheumatology.
[67] A. van der Heide,et al. The Effectiveness of Early Treatment with Second-Line Antirheumatic Drugs , 1996, Annals of Internal Medicine.
[68] J. O'dell,et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. , 1996, The New England journal of medicine.
[69] S. van der Linden,et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis , 1997, The Lancet.
[70] M. Guttadauria,et al. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. , 1983, Arthritis and rheumatism.
[71] Z Domljan,et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. , 1998, Arthritis and rheumatism.
[72] T. Revenson,et al. Assessing the impact of self-efficacy beliefs on adaptation to rheumatoid arthritis. , 1991, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[73] V. Strand,et al. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. , 2000, Arthritis and rheumatism.
[74] J. Kremer,et al. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. , 1992, Arthritis and rheumatism.
[75] P. Hannonen,et al. Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold. , 1998, British journal of rheumatology.
[76] A. Barkun,et al. Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs , 1998 .
[77] R. Makuch,et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.
[78] G. Alarcón,et al. Lack of association between HLA-DR2 and clinical response to methotrexate in patients with rheumatoid arthritis. , 1987, Arthritis and rheumatism.
[79] M. Dougados,et al. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components , 1999, Annals of the rheumatic diseases.
[80] P. Hannonen,et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial , 1999, The Lancet.
[81] F. Epstein,et al. Rheumatoid arthritis. Pathophysiology and implications for therapy. , 1990, The New England journal of medicine.
[82] A. Whelton. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. , 1999, The American journal of medicine.
[83] M. Picot,et al. Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study. , 1997, British journal of rheumatology.
[84] T. Revenson. The role of social support with rheumatic disease. , 1993, Bailliere's clinical rheumatology.
[85] F. Wolfe,et al. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. , 1998, Arthritis and rheumatism.
[86] H. Genant,et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. , 2000, Arthritis and rheumatism.
[87] J. Block,et al. The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial. , 1999, Arthritis and rheumatism.
[88] M. Weisman,et al. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[89] P. Tugwell,et al. Renal biopsy findings and followup of renal function in rheumatoid arthritis patients treated with cyclosporin A. An update from the International Kidney Biopsy Registry. , 1996, Arthritis and rheumatism.
[90] P. Dawes,et al. Should disease-modifying agents be used in mild rheumatoid arthritis? , 1991, British journal of rheumatology.
[91] D. Felson,et al. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. , 1990, Arthritis and rheumatism.
[92] R Day,et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.
[93] P. Tugwell,et al. Hydroxychloroquine Compared with Placebo in Rheumatoid Arthritis , 1993, Annals of Internal Medicine.
[94] S D Cook,et al. Long-term follow-up of pyrolytic carbon metacarpophalangeal implants. , 1999, The Journal of bone and joint surgery. American volume.
[95] D. Lubeck,et al. Outcomes of self-help education for patients with arthritis. , 1985, Arthritis and rheumatism.
[96] P. Lipsky,et al. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial , 1999, The Lancet.
[97] C. Hawkey,et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. , 1998, The New England journal of medicine.
[98] F. Salaffi,et al. Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis. , 1996, Scandinavian journal of rheumatology.
[99] K. Kuntz,et al. A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[100] R. M. Mason,et al. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. , 1975, Annals of the rheumatic diseases.
[101] M. Cohen,et al. Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. , 1995, The American journal of medicine.
[102] D. Mitchell,et al. Preliminary criteria for clinical remission in rheumatoid arthritis. , 1981, Arthritis and rheumatism.
[103] F. Wolfe,et al. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. , 1994, Arthritis and rheumatism.
[104] R. Altman,et al. Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis. , 1992, The American journal of medicine.
[105] G. Alarcón,et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. , 1990, Arthritis and rheumatism.
[106] H T Hatoum,et al. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. , 1996, Archives of internal medicine.
[107] H K Genant,et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? , 1985, Arthritis and rheumatism.
[108] J. Kirwan,et al. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. , 1998, British journal of rheumatology.
[109] P. Tugwell,et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. , 1995, The New England journal of medicine.
[110] J. Callaghan,et al. Total Hip Arthroplasty with Cement in Patients Who Have Rheumatoid Arthritis. A Minimum Ten-Year Follow-up Study* , 1998, The Journal of bone and joint surgery. American volume.
[111] M. Urowitz,et al. Azathioprine in rheumatoid arthritis. A double-blind, cross over study. , 1973, Arthritis & Rheumatism.
[112] P. Gertman,et al. Measuring health status in arthritis. The arthritis impact measurement scales. , 1980, Arthritis and rheumatism.
[113] G. Iverson,et al. Cognitive-behavioral approaches to pain management in rheumatoid arthritis. , 1993, Arthritis care and research : the official journal of the Arthritis Health Professions Association.